Leukocyte Growth Factor [EPC]

Leukocyte Growth Factor [EPC] was reported 142787 times

Drugs of the Leukocyte Growth Factor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 149 0.9739
1 THYMUS HYPOPLASIA 147 0.8448
2 DEVICE ADHESION ISSUE 11940 0.7774
3 UNINTENTIONAL MEDICAL DEVICE REMOVAL 8999 0.7771
4 HUMAN BOCAVIRUS INFECTION 124 0.6561
5 DEVICE ELECTRICAL FINDING 409 0.5777
6 MAGNETIC RESONANCE IMAGING 71 0.5504
7 APPLICATION SITE HAEMORRHAGE 1398 0.5113
8 BLOOD STEM CELL HARVEST FAILURE 67 0.4527
9 COLONY STIMULATING FACTOR THERAPY 85 0.4106
10 NEUROBLASTOMA RECURRENT 81 0.3990
11 NUCLEAR MAGNETIC RESONANCE IMAGING 56 0.3373
12 CYSTITIS BACTERIAL 110 0.3254
13 NOROVIRUS TEST POSITIVE 94 0.2892
14 APPLICATION SITE BRUISE 278 0.2857
15 AORTITIS 189 0.2755
16 DEVICE OCCLUSION 3406 0.2418
17 APPLICATION SITE DISCOMFORT 420 0.2336
18 MYCOBACTERIUM CHELONAE INFECTION 169 0.2287
19 OCCUPATIONAL EXPOSURE TO PRODUCT 1425 0.2214
20 DISSEMINATED ASPERGILLOSIS 104 0.2203
21 MENINGITIS TUBERCULOUS 117 0.2093
22 SECONDARY IMMUNODEFICIENCY 239 0.1967
23 ABSCESS BACTERIAL 71 0.1956
24 DEVICE PHYSICAL PROPERTY ISSUE 1422 0.1854
25 DEVICE USE ERROR 6087 0.1750
26 TISSUE INFILTRATION 50 0.1695
27 DEVICE POWER SOURCE ISSUE 486 0.1663
28 PSEUDOMONAL SEPSIS 275 0.1569
29 ENGRAFT FAILURE 44 0.1533
30 CORONA VIRUS INFECTION 59 0.1372
31 NEUTROPENIC INFECTION 123 0.1285
32 INTERCEPTED PRODUCT PREPARATION ERROR 1580 0.1282
33 NEUTROPHIL COUNT ABNORMAL 361 0.1276
34 INVESTIGATION 396 0.1262
35 FEBRILE NEUTROPENIA 8113 0.1222
36 DEVICE ALARM ISSUE 214 0.1178
37 COMPUTERISED TOMOGRAM THORAX ABNORMAL 79 0.1150
38 DEVICE MALFUNCTION 7891 0.1122
39 INCORRECT DISPOSAL OF PRODUCT 360 0.1107
40 PARAINFLUENZAE VIRUS INFECTION 168 0.1103
41 DEVICE BATTERY ISSUE 70 0.1064
42 ENGRAFTMENT SYNDROME 57 0.0964
43 NEUTROPENIC COLITIS 199 0.0961
44 ENTEROBACTER INFECTION 158 0.0939
45 NEUTROPENIC SEPSIS 663 0.0927
46 ACUTE MYELOID LEUKAEMIA RECURRENT 195 0.0907
47 HUMAN HERPESVIRUS 6 INFECTION 169 0.0893
48 ARTERITIS 51 0.0807
49 DIFFUSE ALVEOLAR DAMAGE 92 0.0800
50 VIRAEMIA 106 0.0765
51 PSEUDOMONAL BACTERAEMIA 59 0.0691
52 SPLENIC RUPTURE 113 0.0687
53 WHITE BLOOD CELL COUNT ABNORMAL 431 0.0675
54 BONE PAIN 3938 0.0672
55 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 62 0.0670
56 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 63 0.0665
57 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 66 0.0655
58 TRIPLE NEGATIVE BREAST CANCER 44 0.0654
59 ESCHERICHIA BACTERAEMIA 153 0.0650
60 STAPHYLOCOCCAL BACTERAEMIA 270 0.0621
61 VIRAL HAEMORRHAGIC CYSTITIS 44 0.0618
62 CYTOMEGALOVIRUS CHORIORETINITIS 120 0.0615
63 CYTOMEGALOVIRUS VIRAEMIA 271 0.0609
64 APLASIA 119 0.0607
65 UTERINE ENLARGEMENT 47 0.0592
66 DEVICE ISSUE 5310 0.0591
67 APPLICATION SITE PAIN 1285 0.0583
68 STREPTOCOCCAL SEPSIS 69 0.0582
69 DEVICE FAILURE 883 0.0579
70 FEBRILE BONE MARROW APLASIA 243 0.0571
71 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 41 0.0570
72 INTERCEPTED PRODUCT ADMINISTRATION ERROR 432 0.0563
73 DEVICE PLACEMENT ISSUE 201 0.0561
74 STREPTOCOCCAL BACTERAEMIA 61 0.0561
75 KLEBSIELLA BACTERAEMIA 52 0.0547
76 CAPILLARY LEAK SYNDROME 111 0.0536
77 PSYCHOLOGICAL TRAUMA 452 0.0523
78 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10370 0.0511
79 FEBRILE INFECTION 60 0.0510
80 PNEUMATOSIS INTESTINALIS 144 0.0504
81 PLATELET TRANSFUSION 64 0.0497
82 CLOSTRIDIUM DIFFICILE COLITIS 526 0.0496
83 ACCIDENTAL EXPOSURE TO PRODUCT 5107 0.0495
84 MUCOSAL INFLAMMATION 1257 0.0480
85 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 132 0.0477
86 RHINOVIRUS INFECTION 185 0.0475
87 KLEBSIELLA SEPSIS 53 0.0470
88 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 66 0.0467
89 PERIPHERAL MOTOR NEUROPATHY 64 0.0456
90 NEUTROPENIA 6186 0.0454
91 APLASTIC ANAEMIA 235 0.0450
92 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 103 0.0442
93 NEUTROPHIL COUNT DECREASED 1784 0.0437
94 PERIPHERAL SENSORY NEUROPATHY 253 0.0432
95 SUBCLAVIAN VEIN THROMBOSIS 49 0.0430
96 ACUTE GRAFT VERSUS HOST DISEASE 197 0.0430
97 CYSTITIS HAEMORRHAGIC 171 0.0424
98 HAIR DISORDER 347 0.0421
99 STEM CELL TRANSPLANT 104 0.0416
100 BRONCHOPULMONARY ASPERGILLOSIS 321 0.0414
101 ALOPECIA AREATA 72 0.0410
102 PRODUCT COMMUNICATION ISSUE 361 0.0409
103 TRANSITIONAL CELL CARCINOMA 53 0.0408
104 PNEUMONIA KLEBSIELLA 75 0.0408
105 WHITE BLOOD CELL DISORDER 109 0.0407
106 GASTROENTERITIS NOROVIRUS 54 0.0406
107 CYTOMEGALOVIRUS TEST POSITIVE 72 0.0404
108 CHRONIC GRAFT VERSUS HOST DISEASE 142 0.0393
109 CHEMOTHERAPY 147 0.0388
110 VENOOCCLUSIVE LIVER DISEASE 189 0.0382
111 BLOOD CULTURE POSITIVE 114 0.0380
112 ESCHERICHIA SEPSIS 108 0.0372
113 SYSTEMIC INFECTION 61 0.0368
114 DRUG DELIVERY SYSTEM MALFUNCTION 188 0.0367
115 ENTERITIS 231 0.0361
116 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 92 0.0356
117 CYTOKINE RELEASE SYNDROME 714 0.0356
118 ALVEOLITIS 50 0.0354
119 HAIR COLOUR CHANGES 440 0.0353
120 PANCYTOPENIA 1966 0.0351
121 ACUTE MYELOID LEUKAEMIA 548 0.0351
122 HYPOALBUMINAEMIA 273 0.0351
123 OESOPHAGEAL CANDIDIASIS 137 0.0343
124 DEVICE LEAKAGE 1490 0.0343
125 MADAROSIS 398 0.0343
126 STENOTROPHOMONAS INFECTION 46 0.0339
127 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1124 0.0332
128 BACTERIAL INFECTION 615 0.0329
129 HAIR TEXTURE ABNORMAL 440 0.0329
130 PNEUMONIA FUNGAL 128 0.0324
131 OSTEOSCLEROSIS 51 0.0324
132 VENOOCCLUSIVE DISEASE 81 0.0323
133 OSTEOLYSIS 66 0.0323
134 SYSTEMIC CANDIDA 81 0.0322
135 LEUKAEMIA RECURRENT 53 0.0313
136 BACTERIAL SEPSIS 102 0.0313
137 ATELECTASIS 302 0.0312
138 LEUKOCYTOSIS 561 0.0310
139 SPLENIC INFARCTION 54 0.0309
140 STAPHYLOCOCCAL SEPSIS 152 0.0308
141 VENOUS THROMBOSIS 120 0.0305
142 KLEBSIELLA INFECTION 154 0.0304
143 MYELODYSPLASTIC SYNDROME 434 0.0300
144 ENTEROCOCCAL INFECTION 144 0.0298
145 TRANSPLANT FAILURE 72 0.0293
146 RADIOTHERAPY 56 0.0293
147 GRAFT VERSUS HOST DISEASE 210 0.0292
148 ACUTE LYMPHOCYTIC LEUKAEMIA 82 0.0289
149 BONE MARROW DISORDER 87 0.0288
150 HAEMATOTOXICITY 272 0.0286
151 BONE MARROW FAILURE 580 0.0285
152 LYMPHOPENIA 400 0.0283
153 DRUG DOSE OMISSION BY DEVICE 2185 0.0279
154 CYTOMEGALOVIRUS INFECTION REACTIVATION 123 0.0278
155 GRAFT VERSUS HOST DISEASE IN SKIN 61 0.0277
156 THROMBOCYTOPENIA 3092 0.0276
157 BACTERAEMIA 327 0.0275
158 PRODUCT PREPARATION ERROR 566 0.0275
159 FUNGAEMIA 43 0.0273
160 PLASMA CELL MYELOMA RECURRENT 88 0.0271
161 TUMOUR LYSIS SYNDROME 235 0.0267
162 SPLENOMEGALY 311 0.0265
163 LEUKOPENIA 1316 0.0263
164 GENE MUTATION 52 0.0262
165 WHITE BLOOD CELL COUNT DECREASED 2845 0.0262
166 SOFT TISSUE INFECTION 48 0.0262
167 HERPES SIMPLEX 170 0.0261
168 CYTOPENIA 319 0.0260
169 ADENOVIRUS INFECTION 75 0.0258
170 BONE MARROW TRANSPLANT 49 0.0258
171 BK VIRUS INFECTION 87 0.0258
172 NEUTROPHIL COUNT INCREASED 262 0.0256
173 ESCHERICHIA INFECTION 204 0.0248
174 BODY TEMPERATURE ABNORMAL 45 0.0244
175 INTERCEPTED MEDICATION ERROR 112 0.0241
176 LUNG INFILTRATION 213 0.0241
177 SKIN TOXICITY 136 0.0240
178 VASCULAR DEVICE INFECTION 107 0.0236
179 LYMPHADENITIS 57 0.0235
180 ASPERGILLUS INFECTION 154 0.0234
181 PNEUMONIA CYTOMEGALOVIRAL 45 0.0231
182 PNEUMOCYSTIS JIROVECI PNEUMONIA 51 0.0229
183 SEPTIC SHOCK 995 0.0228
184 HYPOPHOSPHATAEMIA 168 0.0227
185 NEEDLE ISSUE 660 0.0226
186 PARONYCHIA 98 0.0223
187 PSEUDOMONAS INFECTION 191 0.0223
188 PULMONARY TOXICITY 157 0.0222
189 BONE LESION 80 0.0222
190 GASTROINTESTINAL TOXICITY 106 0.0220
191 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 48 0.0217
192 CYTOMEGALOVIRUS INFECTION 359 0.0216
193 NON-CARDIAC CHEST PAIN 67 0.0212
194 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 124 0.0209
195 DIFFUSE LARGE B-CELL LYMPHOMA 160 0.0207
196 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 79 0.0207
197 SEPSIS 2290 0.0205
198 HYPERPHOSPHATAEMIA 44 0.0204
199 ACUTE RESPIRATORY DISTRESS SYNDROME 361 0.0204
200 CLOSTRIDIUM TEST POSITIVE 45 0.0204
201 PERIODONTITIS 44 0.0203
202 WHITE BLOOD CELL COUNT INCREASED 777 0.0202
203 INCORRECT DOSE ADMINISTERED BY DEVICE 530 0.0202
204 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 43 0.0202
205 LUNG CONSOLIDATION 56 0.0200
206 METASTASES TO LYMPH NODES 135 0.0200
207 HYPOKALAEMIA 904 0.0196
208 LYMPHOCYTOSIS 42 0.0195
209 ORAL CANDIDIASIS 256 0.0194
210 BREAST CANCER RECURRENT 61 0.0193
211 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 96 0.0192
212 PSEUDOMEMBRANOUS COLITIS 43 0.0192
213 AGRANULOCYTOSIS 356 0.0191
214 THROMBOPHLEBITIS 67 0.0191
215 NEUROLOGICAL DECOMPENSATION 44 0.0190
216 INTRACARDIAC THROMBUS 58 0.0189
217 NEOPLASM RECURRENCE 64 0.0189
218 HYPOGAMMAGLOBULINAEMIA 124 0.0189
219 HYPOMAGNESAEMIA 262 0.0188
220 HEPATOSPLENOMEGALY 48 0.0187
221 ODYNOPHAGIA 111 0.0186
222 CHRONIC LYMPHOCYTIC LEUKAEMIA 88 0.0185
223 LEFT VENTRICULAR DYSFUNCTION 124 0.0185
224 BLOOD LACTATE DEHYDROGENASE INCREASED 287 0.0181
225 STREPTOCOCCAL INFECTION 99 0.0178
226 PNEUMOCYSTIS JIROVECII PNEUMONIA 178 0.0177
227 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 146 0.0177
228 PLATELET COUNT ABNORMAL 107 0.0177
229 MULTIPLE ORGAN DYSFUNCTION SYNDROME 499 0.0176
230 THERAPY PARTIAL RESPONDER 274 0.0175
231 POLYNEUROPATHY 210 0.0175
232 THROMBOTIC MICROANGIOPATHY 170 0.0174
233 PNEUMONITIS 471 0.0173
234 TRANSFUSION 181 0.0173
235 BLOOD MAGNESIUM DECREASED 148 0.0171
236 ENTEROCOLITIS 99 0.0171
237 NEUROPATHY PERIPHERAL 1631 0.0171
238 DEVICE RELATED INFECTION 263 0.0171
239 B-CELL LYMPHOMA 58 0.0171
240 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 128 0.0170
241 ANAEMIA 3219 0.0169
242 CANDIDA INFECTION 284 0.0168
243 PLATELET COUNT DECREASED 1776 0.0166
244 LYMPHOEDEMA 114 0.0165
245 HYPOXIA 578 0.0164
246 EJECTION FRACTION DECREASED 255 0.0164
247 CLOSTRIDIAL INFECTION 55 0.0162
248 CHRONIC SINUSITIS 61 0.0162
249 NASAL DISORDER 43 0.0162
250 EMBOLISM 133 0.0160
251 PULMONARY HAEMORRHAGE 125 0.0160
252 RECURRENT CANCER 65 0.0159
253 CENTRAL VENOUS CATHETERISATION 48 0.0159
254 PYREXIA 5498 0.0159
255 ATYPICAL PNEUMONIA 47 0.0157
256 ABDOMINAL MASS 42 0.0157
257 METASTASES TO CENTRAL NERVOUS SYSTEM 200 0.0155
258 APPLICATION SITE DISCOLOURATION 63 0.0155
259 HISTIOCYTOSIS HAEMATOPHAGIC 46 0.0155
260 METASTASES TO SPINE 52 0.0155
261 REFUSAL OF TREATMENT BY PATIENT 101 0.0155
262 MULTIPLE MYELOMA 72 0.0154
263 DEVICE DEPLOYMENT ISSUE 197 0.0154
264 ORGANISING PNEUMONIA 76 0.0153
265 DYSAESTHESIA 47 0.0153
266 VASCULITIS 178 0.0153
267 PLEURITIC PAIN 42 0.0152
268 CANDIDIASIS 61 0.0152
269 UNDERDOSE 1107 0.0151
270 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 352 0.0151
271 ABDOMINAL TENDERNESS 74 0.0149
272 MULTI-ORGAN FAILURE 257 0.0149
273 TONGUE ULCERATION 50 0.0148
274 FLUID INTAKE REDUCED 74 0.0148
275 BLOOD DISORDER 118 0.0147
276 HYPERPYREXIA 62 0.0146
277 FIBROSIS 45 0.0146
278 HYPERURICAEMIA 60 0.0146
279 PRODUCT STORAGE ERROR 1275 0.0145
280 STOMATITIS 881 0.0145
281 PHLEBITIS 74 0.0144
282 HYDRONEPHROSIS 108 0.0144
283 OESOPHAGITIS 157 0.0144
284 RED CELL DISTRIBUTION WIDTH INCREASED 59 0.0142
285 VARICOSE VEIN 73 0.0141
286 HYPERBILIRUBINAEMIA 146 0.0141
287 FIBRIN D DIMER INCREASED 50 0.0141
288 BLOOD CREATININE DECREASED 44 0.0140
289 DEVICE DELIVERY SYSTEM ISSUE 384 0.0140
290 CACHEXIA 72 0.0140
291 ORAL PAIN 313 0.0140
292 COLITIS 527 0.0139
293 PLEURAL EFFUSION 844 0.0139
294 NEUROTOXICITY 242 0.0138
295 SINUS TACHYCARDIA 196 0.0138
296 ELECTROLYTE IMBALANCE 160 0.0138
297 ERYSIPELAS 69 0.0137
298 LYMPHADENOPATHY 486 0.0137
299 APLASIA PURE RED CELL 47 0.0136
300 SECOND PRIMARY MALIGNANCY 113 0.0136
301 LIVER ABSCESS 44 0.0136
302 BLOOD CREATINE INCREASED 60 0.0135
303 PLASMA CELL MYELOMA 528 0.0135
304 HAEMATOCRIT DECREASED 267 0.0135
305 ESCHERICHIA URINARY TRACT INFECTION 57 0.0134
306 BLOOD COUNT ABNORMAL 203 0.0134
307 DRUG DOSE OMISSION 2202 0.0133
308 NEUTROPHILIA 75 0.0132
309 VIRAL INFECTION 437 0.0131
310 RASH MACULO-PAPULAR 291 0.0131
311 OTITIS MEDIA 43 0.0130
312 PROTEIN TOTAL DECREASED 49 0.0130
313 RESPIRATORY FAILURE 946 0.0130
314 METASTASES TO LIVER 228 0.0130
315 HAEMOGLOBIN ABNORMAL 83 0.0129
316 CLOSTRIDIUM DIFFICILE INFECTION 281 0.0129
317 CELLULITIS 648 0.0128
318 APPLICATION SITE SWELLING 64 0.0128
319 THROMBOCYTOSIS 47 0.0128
320 HYPOCALCAEMIA 242 0.0128
321 ENCEPHALITIS 88 0.0127
322 BREAST CANCER METASTATIC 136 0.0127
323 RED BLOOD CELL COUNT DECREASED 362 0.0126
324 DERMATITIS EXFOLIATIVE GENERALISED 44 0.0126
325 GRANULOCYTOPENIA 72 0.0126
326 ACUTE RESPIRATORY FAILURE 243 0.0126
327 SPINAL PAIN 148 0.0126
328 FULL BLOOD COUNT DECREASED 254 0.0126
329 LYMPHOCYTE COUNT DECREASED 222 0.0125
330 HEART RATE ABNORMAL 70 0.0125
331 DISEASE PROGRESSION 1479 0.0125
332 NAIL DISCOLOURATION 49 0.0125
333 CARDIOTOXICITY 111 0.0124
334 IMPAIRED QUALITY OF LIFE 178 0.0124
335 DERMATITIS ACNEIFORM 75 0.0123
336 C-REACTIVE PROTEIN INCREASED 448 0.0123
337 RESPIRATORY SYNCYTIAL VIRUS INFECTION 107 0.0123
338 METASTASES TO BONE 200 0.0122
339 NEPHROPATHY TOXIC 134 0.0119
340 FUNGAL INFECTION 397 0.0119
341 FAILURE TO THRIVE 61 0.0117
342 ILEUS 146 0.0117
343 PYODERMA GANGRENOSUM 42 0.0117
344 ORAL HERPES 227 0.0116
345 ALOPECIA 2271 0.0116
346 LYMPHOMA 178 0.0115
347 HYPERCALCAEMIA 142 0.0115
348 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 58 0.0114
349 INFECTION 1643 0.0113
350 BODY TEMPERATURE INCREASED 231 0.0113
351 BLOOD ALKALINE PHOSPHATASE INCREASED 279 0.0112
352 ASCITES 330 0.0112
353 DISSEMINATED INTRAVASCULAR COAGULATION 158 0.0112
354 HAEMOGLOBIN DECREASED 1151 0.0112
355 EPSTEIN-BARR VIRUS INFECTION 70 0.0112
356 INGUINAL HERNIA 68 0.0112
357 MUSCULOSKELETAL CHEST PAIN 173 0.0112
358 NO THERAPEUTIC RESPONSE 136 0.0111
359 HEPATIC LESION 48 0.0111
360 METASTATIC NEOPLASM 47 0.0109
361 TRICUSPID VALVE INCOMPETENCE 86 0.0108
362 METASTASES TO LUNG 125 0.0108
363 LEUKAEMIA 102 0.0108
364 UROSEPSIS 98 0.0106
365 HICCUPS 87 0.0106
366 GAMMA-GLUTAMYLTRANSFERASE INCREASED 233 0.0105
367 HYPERTHERMIA 80 0.0105
368 BLOOD ALBUMIN DECREASED 83 0.0105
369 DEVICE OPERATIONAL ISSUE 45 0.0105
370 SERUM FERRITIN INCREASED 55 0.0104
371 HYPERHIDROSIS 1338 0.0104
372 HYPONATRAEMIA 585 0.0104
373 SPINAL OSTEOARTHRITIS 91 0.0103
374 TONSILLITIS 54 0.0103
375 RENAL CYST 82 0.0103
376 COVID-19 PNEUMONIA 121 0.0102
377 STAPHYLOCOCCAL INFECTION 338 0.0102
378 HYPERGLYCAEMIA 373 0.0102
379 LUNG INFECTION 159 0.0102
380 MONOPLEGIA 44 0.0101
381 PETECHIAE 105 0.0101
382 NEOPLASM PROGRESSION 348 0.0100
383 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
384 NAIL DISORDER 87 0.0099
385 TOXIC EPIDERMAL NECROLYSIS 151 0.0099
386 BLOOD BILIRUBIN INCREASED 268 0.0099
387 MOUTH ULCERATION 209 0.0099
388 PERFORMANCE STATUS DECREASED 46 0.0098
389 INTERVERTEBRAL DISC DISORDER 42 0.0098
390 SKIN INFECTION 110 0.0098
391 TUMOUR MARKER INCREASED 47 0.0098
392 MALNUTRITION 109 0.0097
393 HYPOVOLAEMIA 57 0.0097
394 BLOOD LACTIC ACID INCREASED 51 0.0097
395 PATHOLOGICAL FRACTURE 49 0.0096
396 PROCTALGIA 62 0.0096
397 HYPERTRIGLYCERIDAEMIA 56 0.0096
398 BLOOD URIC ACID INCREASED 55 0.0095
399 HEPATOTOXICITY 212 0.0095
400 GUILLAIN-BARRE SYNDROME 46 0.0095
401 PNEUMONIA 3076 0.0095
402 DEHYDRATION 1265 0.0095
403 INTERSTITIAL LUNG DISEASE 457 0.0094
404 TENDERNESS 98 0.0094
405 GASTROENTERITIS 137 0.0094
406 RASH PUSTULAR 68 0.0093
407 PERIORBITAL OEDEMA 48 0.0092
408 DEVICE DEFECTIVE 160 0.0092
409 CORONAVIRUS INFECTION 61 0.0092
410 NON-SMALL CELL LUNG CANCER 44 0.0092
411 BRAIN OEDEMA 116 0.0092
412 SMALL INTESTINAL OBSTRUCTION 113 0.0092
413 MYELOSUPPRESSION 330 0.0092
414 DEEP VEIN THROMBOSIS 591 0.0091
415 IMMUNOSUPPRESSION 80 0.0091
416 PNEUMONIA BACTERIAL 82 0.0089
417 LARGE INTESTINE PERFORATION 62 0.0089
418 INTESTINAL PERFORATION 100 0.0089
419 ATRIAL FLUTTER 71 0.0089
420 FLANK PAIN 83 0.0088
421 DECUBITUS ULCER 72 0.0088
422 SUPRAVENTRICULAR TACHYCARDIA 84 0.0088
423 ASPARTATE AMINOTRANSFERASE INCREASED 466 0.0088
424 FACE OEDEMA 147 0.0087
425 ANOREXIA 112 0.0087
426 HERPES VIRUS INFECTION 50 0.0087
427 NECROSIS 48 0.0086
428 HOSPITALISATION 1324 0.0086
429 ECCHYMOSIS 59 0.0086
430 COLITIS ISCHAEMIC 58 0.0086
431 GENERAL PHYSICAL HEALTH DETERIORATION 993 0.0086
432 PNEUMOTHORAX 136 0.0086
433 ALANINE AMINOTRANSFERASE INCREASED 526 0.0086
434 METASTASIS 61 0.0085
435 TACHYPNOEA 115 0.0084
436 HYPOPHAGIA 216 0.0084
437 HEPATOMEGALY 83 0.0084
438 PAIN IN JAW 239 0.0084
439 HAEMOLYSIS 65 0.0084
440 BLOOD CALCIUM DECREASED 94 0.0084
441 COAGULOPATHY 139 0.0083
442 LABORATORY TEST ABNORMAL 246 0.0083
443 BREATH SOUNDS ABNORMAL 41 0.0083
444 APHTHOUS ULCER 64 0.0082
445 MUSCULOSKELETAL PAIN 432 0.0082
446 CIRCULATORY COLLAPSE 139 0.0082
447 GENERALISED OEDEMA 101 0.0082
448 OFF LABEL USE 7143 0.0081
449 ENCEPHALOPATHY 200 0.0081
450 BLOOD UREA INCREASED 136 0.0081
451 CARDIOMYOPATHY 120 0.0081
452 RESPIRATORY DISTRESS 224 0.0081
453 EPISTAXIS 607 0.0081
454 TRANSAMINASES INCREASED 180 0.0081
455 PULMONARY FIBROSIS 155 0.0081
456 RESPIRATORY TRACT INFECTION 210 0.0081
457 PULMONARY EMBOLISM 766 0.0081
458 BACK PAIN 1862 0.0080
459 PERICARDIAL EFFUSION 185 0.0080
460 PRODUCT DOSE OMISSION 522 0.0080
461 ATRIAL FIBRILLATION 778 0.0080
462 UPPER RESPIRATORY TRACT INFECTION 368 0.0080
463 ORAL DISORDER 58 0.0079
464 UNEVALUABLE EVENT 598 0.0079
465 PRODUCT LABEL CONFUSION 46 0.0079
466 TACHYCARDIA 697 0.0078
467 TOXIC SKIN ERUPTION 79 0.0078
468 HAEMORRHAGE INTRACRANIAL 117 0.0078
469 BLOOD POTASSIUM DECREASED 235 0.0078
470 HAEMOLYTIC ANAEMIA 70 0.0078
471 BONE DISORDER 142 0.0078
472 RENAL FAILURE ACUTE 328 0.0077
473 TRANSPLANT REJECTION 61 0.0076
474 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 59 0.0076
475 THERAPY NON-RESPONDER 341 0.0076
476 HAEMORRHOIDS 146 0.0075
477 HEPATIC CYTOLYSIS 95 0.0074
478 PYELONEPHRITIS 64 0.0074
479 BLOOD CREATININE INCREASED 482 0.0074
480 DECREASED APPETITE 1713 0.0074
481 DEVICE MECHANICAL ISSUE 101 0.0074
482 PURPURA 65 0.0073
483 CONSTIPATION 1602 0.0073
484 HYPOTENSION 1469 0.0073
485 PROTEINURIA 139 0.0073
486 HEPATIC FAILURE 220 0.0073
487 PULMONARY MASS 108 0.0072
488 MENTAL STATUS CHANGES 201 0.0072
489 OSTEOMYELITIS 131 0.0072
490 SYNCOPE 721 0.0072
491 BLOOD TEST ABNORMAL 101 0.0072
492 DIVERTICULUM 51 0.0072
493 SKIN REACTION 101 0.0072
494 CYSTITIS 227 0.0071
495 LOWER RESPIRATORY TRACT INFECTION 324 0.0071
496 OSTEONECROSIS OF JAW 176 0.0071
497 NIGHT SWEATS 228 0.0071
498 MYOCARDITIS 81 0.0071
499 DERMATITIS BULLOUS 51 0.0070
500 HYPERTRANSAMINASAEMIA 49 0.0070
501 GINGIVAL PAIN 56 0.0070
502 CHILLS 821 0.0070
503 FULL BLOOD COUNT ABNORMAL 74 0.0070
504 DEATH 6025 0.0070
505 MITRAL VALVE INCOMPETENCE 79 0.0070
506 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 496 0.0070
507 MALIGNANT NEOPLASM PROGRESSION 710 0.0069
508 ACUTE KIDNEY INJURY 1060 0.0069
509 INCORRECT PRODUCT STORAGE 91 0.0069
510 DIARRHOEA 4463 0.0069
511 SUDDEN DEATH 73 0.0069
512 HOSPICE CARE 68 0.0069
513 TOOTH ABSCESS 70 0.0069
514 PHARYNGITIS 85 0.0068
515 HYPOTHYROIDISM 218 0.0068
516 HAEMATURIA 232 0.0068
517 CHOLANGITIS 42 0.0068
518 SPINAL COMPRESSION FRACTURE 56 0.0068
519 ADRENAL INSUFFICIENCY 82 0.0068
520 OEDEMA 364 0.0067
521 NEPHROTIC SYNDROME 46 0.0067
522 PULMONARY CONGESTION 88 0.0067
523 LOW BIRTH WEIGHT BABY 53 0.0067
524 CARDIOMEGALY 82 0.0067
525 DYSPNOEA EXERTIONAL 251 0.0067
526 ABSCESS 106 0.0066
527 NEURALGIA 160 0.0066
528 TERMINAL STATE 44 0.0066
529 FLUID OVERLOAD 95 0.0065
530 BLOOD SODIUM DECREASED 122 0.0065
531 SKIN LESION 177 0.0064
532 ABDOMINAL PAIN 1497 0.0064
533 VOMITING 3013 0.0064
534 ACUTE CORONARY SYNDROME 53 0.0064
535 LIPASE INCREASED 49 0.0064
536 ONYCHOCLASIS 44 0.0064
537 HEPATIC STEATOSIS 119 0.0064
538 EAR PAIN 124 0.0064
539 PLATELET COUNT INCREASED 83 0.0064
540 MYALGIA 1078 0.0063
541 SENSORY LOSS 51 0.0063
542 ASTHENIA 2350 0.0062
543 CHOLECYSTITIS 74 0.0062
544 DIARRHOEA HAEMORRHAGIC 58 0.0062
545 RESPIRATORY RATE INCREASED 55 0.0062
546 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 59 0.0062
547 GASTROINTESTINAL INFECTION 55 0.0061
548 SPUTUM DISCOLOURED 58 0.0061
549 RHINITIS 49 0.0061
550 URINE OUTPUT DECREASED 53 0.0061
551 TROPONIN INCREASED 46 0.0060
552 INJURY ASSOCIATED WITH DEVICE 123 0.0060
553 OEDEMA PERIPHERAL 736 0.0060
554 MOUTH HAEMORRHAGE 44 0.0060
555 SYRINGE ISSUE 105 0.0060
556 URINARY TRACT INFECTION 1021 0.0060
557 GASTRITIS 157 0.0060
558 THROMBOSIS 479 0.0059
559 HAEMOPTYSIS 166 0.0059
560 DRUG TOXICITY 81 0.0059
561 CHEST PAIN 1101 0.0059
562 INTERVERTEBRAL DISC DEGENERATION 55 0.0059
563 CARDIAC FAILURE 474 0.0059
564 FATIGUE 4590 0.0059
565 APPLICATION SITE ERYTHEMA 154 0.0059
566 NAUSEA 4616 0.0058
567 PULMONARY OEDEMA 261 0.0058
568 LACRIMATION INCREASED 176 0.0058
569 LUNG DISORDER 285 0.0058
570 WOUND INFECTION 63 0.0057
571 ASPIRATION 63 0.0057
572 IRON DEFICIENCY ANAEMIA 53 0.0057
573 HYPERAESTHESIA 47 0.0057
574 INJECTION SITE DISCOMFORT 60 0.0057
575 IMMUNE SYSTEM DISORDER 75 0.0057
576 LOWER GASTROINTESTINAL HAEMORRHAGE 42 0.0057
577 PRESYNCOPE 138 0.0057
578 HAEMODYNAMIC INSTABILITY 43 0.0056
579 SQUAMOUS CELL CARCINOMA 53 0.0056
580 ACIDOSIS 43 0.0056
581 CHOLESTASIS 108 0.0056
582 DYSGEUSIA 417 0.0056
583 WRONG DRUG ADMINISTERED 50 0.0056
584 PRODUCTIVE COUGH 265 0.0055
585 HYPERLIPIDAEMIA 66 0.0055
586 RENAL FAILURE 730 0.0055
587 FACIAL PAIN 49 0.0055
588 NEOPLASM MALIGNANT 366 0.0055
589 TOOTH INFECTION 72 0.0055
590 PELVIC PAIN 99 0.0054
591 SKIN ULCER 140 0.0054
592 OROPHARYNGEAL PAIN 499 0.0054
593 MYOCARDIAL ISCHAEMIA 61 0.0054
594 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 55 0.0054
595 LETHARGY 308 0.0053
596 CONJUNCTIVITIS 99 0.0053
597 BASAL CELL CARCINOMA 83 0.0053
598 TOOTHACHE 96 0.0053
599 ARRHYTHMIA 251 0.0053
600 MUSCULOSKELETAL DISCOMFORT 91 0.0053
601 DYSURIA 193 0.0052
602 GASTROINTESTINAL INFLAMMATION 41 0.0052
603 IMMUNODEFICIENCY 78 0.0052
604 RESPIRATORY DISORDER 156 0.0052
605 PNEUMONIA ASPIRATION 130 0.0052
606 CEREBRAL HAEMORRHAGE 186 0.0052
607 POOR QUALITY DEVICE USED 52 0.0052
608 HAEMATOMA 134 0.0052
609 UPPER GASTROINTESTINAL HAEMORRHAGE 87 0.0052
610 SUBDURAL HAEMATOMA 74 0.0052
611 DYSPNOEA 2921 0.0052
612 BREAST PAIN 55 0.0052
613 DISEASE RECURRENCE 245 0.0051
614 HERPES ZOSTER 295 0.0051
615 SHOCK 117 0.0051
616 MASS 71 0.0051
617 NECK PAIN 283 0.0051
618 HYPERTHYROIDISM 73 0.0050
619 UNRESPONSIVE TO STIMULI 129 0.0050
620 GINGIVAL BLEEDING 68 0.0050
621 ADVERSE EVENT 455 0.0049
622 SUBARACHNOID HAEMORRHAGE 50 0.0049
623 COUGH 1374 0.0049
624 HAEMODIALYSIS 41 0.0049
625 FEEDING DISORDER 99 0.0049
626 OSTEOPENIA 74 0.0049
627 ISCHAEMIC STROKE 87 0.0049
628 PALLOR 132 0.0048
629 ADVERSE REACTION 64 0.0048
630 NO ADVERSE EVENT 871 0.0048
631 HEPATIC FUNCTION ABNORMAL 179 0.0048
632 BLOOD CALCIUM INCREASED 42 0.0048
633 RASH GENERALISED 124 0.0048
634 NEOPLASM 55 0.0048
635 PARAESTHESIA ORAL 69 0.0048
636 OVARIAN CANCER 44 0.0048
637 PULMONARY THROMBOSIS 52 0.0048
638 LOCAL SWELLING 83 0.0048
639 DYSPHAGIA 451 0.0047
640 INFLAMMATION 245 0.0047
641 LIVER FUNCTION TEST ABNORMAL 138 0.0047
642 LIVER DISORDER 210 0.0047
643 GASTRIC ULCER 90 0.0047
644 ULCER 75 0.0047
645 SKIN FISSURES 92 0.0047
646 HYPERKALAEMIA 165 0.0047
647 DENTAL CARIES 52 0.0047
648 RENAL TUBULAR NECROSIS 46 0.0047
649 MYOSITIS 42 0.0047
650 OXYGEN SATURATION DECREASED 262 0.0047
651 EYELID OEDEMA 54 0.0046
652 PRODUCT PACKAGING ISSUE 44 0.0046
653 VENTRICULAR FIBRILLATION 51 0.0046
654 INFUSION RELATED REACTION 304 0.0046
655 DIVERTICULITIS 127 0.0046
656 DERMATITIS 96 0.0046
657 INFLUENZA LIKE ILLNESS 377 0.0046
658 ANAPHYLACTIC REACTION 253 0.0046
659 HYPOKINESIA 66 0.0045
660 STEVENS-JOHNSON SYNDROME 101 0.0045
661 RENAL IMPAIRMENT 381 0.0045
662 PREMATURE DELIVERY 72 0.0045
663 BLOOD PRESSURE DECREASED 300 0.0045
664 PULMONARY HYPERTENSION 94 0.0045
665 EOSINOPHILIA 79 0.0045
666 APPENDICITIS 42 0.0045
667 TASTE DISORDER 91 0.0045
668 PAIN 2745 0.0045
669 ARTERIOSCLEROSIS 42 0.0045
670 PAIN IN EXTREMITY 1314 0.0045
671 EATING DISORDER 94 0.0044
672 RHINORRHOEA 284 0.0044
673 SARS-COV-2 TEST POSITIVE 58 0.0044
674 JAUNDICE 118 0.0044
675 ORTHOSTATIC HYPOTENSION 76 0.0044
676 PERITONITIS 90 0.0043
677 ANAPHYLACTIC SHOCK 112 0.0043
678 LIMB DISCOMFORT 134 0.0043
679 GASTROINTESTINAL DISORDER 387 0.0043
680 CHEST DISCOMFORT 440 0.0043
681 RECTAL HAEMORRHAGE 184 0.0043
682 TOOTH EXTRACTION 53 0.0043
683 PREMATURE BABY 128 0.0042
684 MUSCLE TWITCHING 98 0.0042
685 RED BLOOD CELL SEDIMENTATION RATE INCREASED 47 0.0042
686 WEIGHT DECREASED 1180 0.0042
687 METABOLIC ACIDOSIS 135 0.0042
688 HAEMATEMESIS 106 0.0042
689 RESTLESSNESS 153 0.0042
690 MELAENA 92 0.0042
691 ACUTE MYOCARDIAL INFARCTION 123 0.0042
692 INTERVERTEBRAL DISC PROTRUSION 91 0.0042
693 VENTRICULAR EXTRASYSTOLES 43 0.0041
694 HYPOAESTHESIA 617 0.0041
695 DEVICE DISLOCATION 179 0.0041
696 CONFUSIONAL STATE 665 0.0041
697 SENSORY DISTURBANCE 66 0.0041
698 BEDRIDDEN 54 0.0041
699 SWELLING FACE 266 0.0041
700 APHASIA 123 0.0041
701 DELIRIUM 141 0.0041
702 TOOTH DISORDER 90 0.0040
703 PARAESTHESIA 636 0.0040
704 COGNITIVE DISORDER 188 0.0040
705 MUSCLE ATROPHY 51 0.0040
706 HEPATOCELLULAR INJURY 57 0.0040
707 APPLICATION SITE IRRITATION 50 0.0040
708 URINARY RETENTION 134 0.0040
709 CEREBRAL INFARCTION 98 0.0040
710 WOUND 112 0.0040
711 BRONCHOSPASM 57 0.0040
712 ARTHRALGIA 1658 0.0040
713 PHARYNGEAL OEDEMA 61 0.0040
714 GASTROINTESTINAL HAEMORRHAGE 331 0.0040
715 DRUG ERUPTION 70 0.0039
716 CARDIAC ARREST 326 0.0039
717 DERMATITIS CONTACT 45 0.0039
718 RASH 1712 0.0039
719 FISTULA 44 0.0039
720 DERMATITIS ALLERGIC 49 0.0039
721 URINARY INCONTINENCE 115 0.0039
722 NOCTURIA 47 0.0039
723 IMPAIRED HEALING 127 0.0039
724 HIATUS HERNIA 50 0.0039
725 MALAISE 1693 0.0039
726 PERIPHERAL COLDNESS 53 0.0039
727 ABDOMINAL DISTENSION 401 0.0038
728 RASH PRURITIC 208 0.0038
729 SKIN DISORDER 128 0.0038
730 HEMIPARESIS 65 0.0038
731 VENTRICULAR TACHYCARDIA 63 0.0038
732 DYSPEPSIA 375 0.0038
733 HYPOACUSIS 164 0.0038
734 DIALYSIS 54 0.0038
735 RASH ERYTHEMATOUS 180 0.0038
736 THERAPEUTIC RESPONSE DECREASED 227 0.0037
737 FEELING COLD 104 0.0037
738 PRODUCT USE IN UNAPPROVED INDICATION 912 0.0037
739 MICTURITION URGENCY 42 0.0037
740 DEAFNESS 96 0.0037
741 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 107 0.0036
742 OBESITY 58 0.0036
743 MUSCULAR WEAKNESS 413 0.0036
744 CARDIO-RESPIRATORY ARREST 151 0.0036
745 PANCREATITIS ACUTE 81 0.0036
746 BRONCHITIS 265 0.0036
747 AGEUSIA 89 0.0036
748 HYPERSENSITIVITY 662 0.0036
749 ERYTHEMA 727 0.0035
750 MOBILITY DECREASED 253 0.0035
751 PERICARDITIS 59 0.0035
752 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 60 0.0035
753 LIVER FUNCTION TEST INCREASED 75 0.0035
754 HEART RATE INCREASED 341 0.0034
755 OSTEONECROSIS 113 0.0034
756 MALIGNANT MELANOMA 46 0.0034
757 CARDIOGENIC SHOCK 49 0.0034
758 HOT FLUSH 257 0.0034
759 ABDOMINAL PAIN LOWER 86 0.0034
760 INTESTINAL OBSTRUCTION 128 0.0034
761 SPINAL FRACTURE 68 0.0034
762 DISCOMFORT 207 0.0034
763 ADVERSE DRUG REACTION 303 0.0034
764 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 157 0.0034
765 COLON CANCER 50 0.0034
766 GLOSSODYNIA 75 0.0033
767 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 183 0.0033
768 POLLAKIURIA 139 0.0033
769 HEPATITIS 85 0.0033
770 RIB FRACTURE 68 0.0033
771 SLEEP APNOEA SYNDROME 63 0.0033
772 NODULE 43 0.0033
773 CHOLELITHIASIS 108 0.0033
774 THROAT TIGHTNESS 89 0.0033
775 ABDOMINAL PAIN UPPER 676 0.0033
776 LOSS OF CONSCIOUSNESS 419 0.0033
777 RASH PAPULAR 73 0.0033
778 DYSPHONIA 190 0.0032
779 ACUTE HEPATIC FAILURE 44 0.0032
780 FEELING HOT 197 0.0032
781 COVID-19 563 0.0032
782 MUSCULOSKELETAL DISORDER 61 0.0032
783 NERVOUS SYSTEM DISORDER 100 0.0032
784 LOCALISED INFECTION 77 0.0032
785 FLUSHING 323 0.0032
786 POOR QUALITY SLEEP 68 0.0032
787 SKIN DISCOLOURATION 145 0.0032
788 CONTUSION 299 0.0031
789 HYPERTENSION 655 0.0031
790 GOUT 55 0.0031
791 COLD SWEAT 54 0.0031
792 CYANOSIS 48 0.0030
793 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78 0.0030
794 CARDIAC FAILURE CONGESTIVE 243 0.0030
795 SINUSITIS 310 0.0030
796 SWOLLEN TONGUE 94 0.0030
797 HEPATIC ENZYME INCREASED 205 0.0030
798 PALPITATIONS 352 0.0030
799 MUSCLE SPASMS 551 0.0030
800 HAEMORRHAGE 313 0.0030
801 HYPOAESTHESIA ORAL 45 0.0030
802 SCAR 51 0.0030
803 PHOTOSENSITIVITY REACTION 49 0.0030
804 INSOMNIA 790 0.0030
805 DEPRESSED LEVEL OF CONSCIOUSNESS 117 0.0030
806 BLOOD URINE PRESENT 56 0.0029
807 CHROMATURIA 66 0.0029
808 DYSSTASIA 85 0.0029
809 CONVULSION 165 0.0029
810 EPILEPSY 88 0.0029
811 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 150 0.0029
812 BRAIN FOG 45 0.0029
813 DRUG INTOLERANCE 277 0.0029
814 INFLUENZA 319 0.0029
815 DISORIENTATION 113 0.0028
816 LUNG NEOPLASM MALIGNANT 117 0.0028
817 HEADACHE 1784 0.0028
818 BLISTER 159 0.0028
819 SINUS DISORDER 56 0.0028
820 FEELING ABNORMAL 674 0.0028
821 SLEEP DISORDER 198 0.0028
822 PAIN OF SKIN 75 0.0028
823 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 198 0.0028
824 RETCHING 59 0.0028
825 ANXIETY 784 0.0028
826 FLUID RETENTION 140 0.0027
827 SKIN EXFOLIATION 232 0.0027
828 OSTEOARTHRITIS 116 0.0027
829 ELECTROCARDIOGRAM QT PROLONGED 98 0.0027
830 DIZZINESS 1358 0.0027
831 GASTROOESOPHAGEAL REFLUX DISEASE 219 0.0027
832 TRANSIENT ISCHAEMIC ATTACK 91 0.0027
833 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
834 FALL 881 0.0026
835 URTICARIA 441 0.0026
836 HAEMATOCHEZIA 145 0.0026
837 PERIPHERAL SWELLING 404 0.0026
838 ILL-DEFINED DISORDER 159 0.0026
839 DRUG RESISTANCE 67 0.0026
840 PHOTOPHOBIA 49 0.0026
841 LOWER LIMB FRACTURE 50 0.0026
842 EMOTIONAL DISTRESS 315 0.0026
843 RENAL DISORDER 121 0.0026
844 LIP SWELLING 86 0.0026
845 DEVICE USE ISSUE 45 0.0026
846 TOOTH LOSS 53 0.0026
847 SEIZURE 293 0.0025
848 SPEECH DISORDER 132 0.0025
849 FAECES DISCOLOURED 54 0.0025
850 RASH MACULAR 87 0.0025
851 INTENTIONAL PRODUCT USE ISSUE 217 0.0025
852 DRY MOUTH 198 0.0024
853 OSTEOPOROSIS 100 0.0024
854 ABASIA 60 0.0024
855 ACTIVITIES OF DAILY LIVING IMPAIRED 48 0.0024
856 DRY SKIN 323 0.0024
857 TOXICITY TO VARIOUS AGENTS 408 0.0024
858 WHEEZING 143 0.0024
859 ANGINA PECTORIS 69 0.0024
860 SWELLING 225 0.0024
861 POST PROCEDURAL COMPLICATION 46 0.0024
862 INJECTION SITE HAEMORRHAGE 191 0.0024
863 ECZEMA 125 0.0024
864 PRODUCT ADMINISTRATION ERROR 48 0.0024
865 JOINT STIFFNESS 62 0.0024
866 TINNITUS 108 0.0023
867 NASOPHARYNGITIS 429 0.0023
868 INCORRECT DOSE ADMINISTERED 530 0.0023
869 FLATULENCE 131 0.0023
870 PANCREATITIS 122 0.0023
871 SURGERY 135 0.0023
872 APPLICATION SITE PRURITUS 52 0.0023
873 CONDITION AGGRAVATED 695 0.0023
874 ANGIOEDEMA 101 0.0023
875 PRODUCT USE ISSUE 427 0.0023
876 HYPOGLYCAEMIA 110 0.0023
877 BLOOD PRESSURE ABNORMAL 45 0.0023
878 BLOOD CREATINE PHOSPHOKINASE INCREASED 65 0.0023
879 ABDOMINAL DISCOMFORT 375 0.0022
880 TREMOR 371 0.0022
881 DRUG EFFECT INCOMPLETE 81 0.0022
882 VISUAL ACUITY REDUCED 74 0.0022
883 HEART RATE IRREGULAR 50 0.0022
884 PRURITUS 848 0.0022
885 EYE SWELLING 82 0.0022
886 ARTHRITIS 172 0.0022
887 GAIT DISTURBANCE 418 0.0022
888 INCORRECT ROUTE OF DRUG ADMINISTRATION 78 0.0022
889 PANCREATIC CARCINOMA 63 0.0022
890 CARDIAC DISORDER 204 0.0022
891 EAR INFECTION 58 0.0022
892 LIMB INJURY 59 0.0022
893 DYSARTHRIA 81 0.0021
894 MATERNAL EXPOSURE DURING PREGNANCY 191 0.0021
895 CORONARY ARTERY DISEASE 64 0.0021
896 BRADYCARDIA 112 0.0021
897 MEDICATION ERROR 117 0.0021
898 DRUG INTERACTION 333 0.0021
899 NEPHROLITHIASIS 96 0.0021
900 NERVOUSNESS 109 0.0021
901 DEVICE DIFFICULT TO USE 138 0.0021
902 DIPLOPIA 54 0.0021
903 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373 0.0021
904 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
905 RESPIRATORY ARREST 57 0.0021
906 MEMORY IMPAIRMENT 281 0.0020
907 DEMENTIA 57 0.0020
908 BURNING SENSATION 143 0.0020
909 VERTIGO 124 0.0020
910 HYPERSOMNIA 57 0.0020
911 ANHEDONIA 52 0.0020
912 CARDIOVASCULAR DISORDER 50 0.0020
913 VISUAL IMPAIRMENT 243 0.0020
914 MENTAL DISORDER 85 0.0020
915 EYE DISORDER 64 0.0019
916 BREAST CANCER 181 0.0019
917 THERAPY CESSATION 99 0.0019
918 HIP FRACTURE 62 0.0019
919 NASAL CONGESTION 113 0.0019
920 INJECTION SITE PAIN 588 0.0019
921 BALANCE DISORDER 165 0.0019
922 TREATMENT FAILURE 158 0.0019
923 CATARACT 113 0.0019
924 LACTIC ACIDOSIS 61 0.0019
925 DRY EYE 94 0.0019
926 JOINT SWELLING 227 0.0019
927 THROAT IRRITATION 83 0.0018
928 ILLNESS 190 0.0018
929 VISION BLURRED 253 0.0018
930 HEAD INJURY 58 0.0018
931 SOMNOLENCE 368 0.0018
932 DEPRESSION 413 0.0018
933 EXTRA DOSE ADMINISTERED 72 0.0018
934 VAGINAL HAEMORRHAGE 76 0.0017
935 DRUG INEFFECTIVE 2304 0.0017
936 FEAR 47 0.0017
937 BLINDNESS 71 0.0017
938 INJECTION SITE REACTION 119 0.0017
939 INJURY 121 0.0017
940 DEPRESSED MOOD 91 0.0017
941 DRUG ADMINISTRATION ERROR 51 0.0017
942 WEIGHT INCREASED 372 0.0017
943 DRUG-INDUCED LIVER INJURY 52 0.0017
944 RHABDOMYOLYSIS 69 0.0017
945 FOETAL EXPOSURE DURING PREGNANCY 134 0.0016
946 GAIT INABILITY 55 0.0016
947 COMA 78 0.0016
948 AMNESIA 105 0.0016
949 INTENTIONAL PRODUCT MISUSE 141 0.0016
950 DIABETES MELLITUS 122 0.0016
951 PRODUCT DOSE OMISSION ISSUE 464 0.0016
952 BLOOD PRESSURE INCREASED 236 0.0015
953 HALLUCINATION 116 0.0015
954 THERAPY INTERRUPTED 110 0.0015
955 MYOCARDIAL INFARCTION 267 0.0015
956 OCULAR HYPERAEMIA 72 0.0015
957 AGITATION 110 0.0015
958 MUSCULOSKELETAL STIFFNESS 130 0.0015
959 CEREBROVASCULAR ACCIDENT 250 0.0015
960 EMOTIONAL DISORDER 45 0.0015
961 GASTRIC DISORDER 50 0.0015
962 RENAL INJURY 43 0.0014
963 ARTHROPATHY 80 0.0014
964 MIGRAINE 136 0.0014
965 PSYCHOTIC DISORDER 42 0.0014
966 DISTURBANCE IN ATTENTION 76 0.0014
967 TREATMENT NONCOMPLIANCE 75 0.0014
968 EXPOSURE DURING PREGNANCY 85 0.0014
969 FEMUR FRACTURE 42 0.0014
970 ABORTION SPONTANEOUS 50 0.0012
971 PANIC ATTACK 45 0.0012
972 ROAD TRAFFIC ACCIDENT 51 0.0012
973 ACCIDENTAL OVERDOSE 44 0.0012
974 IRRITABILITY 71 0.0012
975 INJECTION SITE ERYTHEMA 142 0.0011
976 THERAPEUTIC PRODUCT EFFECT DECREASED 51 0.0011
977 DYSKINESIA 46 0.0011
978 CRYING 41 0.0011
979 BLOOD GLUCOSE INCREASED 211 0.0011
980 OVERDOSE 231 0.0011
981 INJECTION SITE BRUISING 85 0.0011
982 EYE PAIN 60 0.0011
983 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
984 CHRONIC KIDNEY DISEASE 78 0.0010
985 ASTHMA 102 0.0009
986 AGGRESSION 45 0.0009
987 INJECTION SITE SWELLING 67 0.0009
988 DRUG EFFECT DECREASED 46 0.0009
989 EYE IRRITATION 45 0.0008
990 ACNE 56 0.0007
991 PROSTATE CANCER 57 0.0007
992 PRODUCT QUALITY ISSUE 80 0.0006
993 RHEUMATOID ARTHRITIS 44 0.0004
994 PSORIASIS 45 0.0003